Department of Emergency Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Department of Nursing, Chang Gung University of Science and Technology, Chiayi, Taiwan.
BMC Health Serv Res. 2021 Jan 21;21(1):78. doi: 10.1186/s12913-021-06091-2.
Diabetes mellitus is a known risk factor for infection. Pay for Performance (P4P) program is designed to enhance the comprehensive patient care. The aim of this study is to evaluate the effect of the P4P program on infection incidence in type 2 diabetic patients.
This is a retrospective longitudinal cohort study using data from the National Health Insurance Research Database in Taiwan. Diabetic patients between 1 January 2002 and 31 December 2013 were included. Primary outcomes analyzed were patient emergency room (ER) infection events and deaths.
After propensity score matching, there were 337,184 patients in both the P4P and non-P4P cohort. The results showed that patients' completing one-year P4P program was associated with a decreased risk of any ER infection event (27.2% vs. 29%; subdistribution hazard ratio [HR] 0.87, 95% confidence interval [CI] 0.86-0.88). While the number needed to treat was 58 for the non-P4P group, it dropped to 28 in the P4P group. The risk of infection-related death was significantly lower in the P4P group than in the non-P4P group (4.1% vs. 7.6%; HR 0.46, 95% CI 0.45-0.47). The effect of P4P on ER infection incidence and infection-related death was more apparent in the subgroups of patients who were female, had diabetes duration ≥5 years, chronic kidney disease, higher Charlson's Comorbidity Index scores and infection-related hospitalization in the previous 3 years.
The P4P program might reduce risk of ER infection events and infection-related deaths in type 2 diabetic patients.
糖尿病是已知的感染风险因素。绩效付费(P4P)计划旨在提高全面患者护理水平。本研究旨在评估 P4P 计划对 2 型糖尿病患者感染发生率的影响。
这是一项使用来自台湾全民健康保险研究数据库的数据进行的回顾性纵向队列研究。纳入 2002 年 1 月 1 日至 2013 年 12 月 31 日期间的糖尿病患者。主要分析结果为患者急诊(ER)感染事件和死亡。
在倾向评分匹配后,P4P 组和非 P4P 组各有 337184 名患者。结果表明,患者完成一年的 P4P 计划与降低任何 ER 感染事件的风险相关(27.2%比 29%;亚分布风险比[HR]0.87,95%置信区间[CI]0.86-0.88)。非 P4P 组的需要治疗人数为 58,而 P4P 组则降至 28。P4P 组的感染相关死亡风险明显低于非 P4P 组(4.1%比 7.6%;HR 0.46,95% CI 0.45-0.47)。P4P 对 ER 感染发生率和感染相关死亡的影响在女性、糖尿病病程≥5 年、慢性肾脏病、较高的 Charlson 合并症指数评分和前 3 年感染相关住院的患者亚组中更为明显。
P4P 计划可能降低 2 型糖尿病患者 ER 感染事件和感染相关死亡的风险。